Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation | |
Li, Dongdong1,2; Zhang, Meng1; Xu, Fan1,2; Chen, Yingzhi1; Chen, Binfan1; Chang, Ya1,2; Zhong, Huihai1,3; Jin, Hongyue1; Huang, Yongzhuo1 | |
刊名 | ACTA PHARMACEUTICA SINICA B |
2018-01 | |
卷号 | 8期号:1页码:74-84 |
关键词 | Photothermal therapy Paclitaxel Combination therapy Gold nanorods Albumin Tumor-associated macrophage |
ISSN号 | 2211-3835 |
DOI | 10.1016/j.apsb.2017.09.005 |
文献子类 | Article |
英文摘要 | Nanotechnology-based photothermal therapy has attracted great attention in the past decade. Nevertheless, photothermal therapy has some inherent drawbacks, such as the uneven heat production and limited laser penetration, often leading to insufficient treatment outcomes. Here, we developed a combination strategy to improve cancer therapy. The biomimetic albumin-modified gold nanorods (AuNRs) were prepared with incorporation of paclitaxel (PTX). This therapeutic system was characterized by several features. First, the albumin modification enhanced the biocompatibility and colloidal stability. Second, the surface-coated albumin promoted cellular uptake via the albumin-binding protein pathway. Third, PTX was incorporated via hydrophobic interaction between PTX and the albumin lipophilic domain. Fourth, the system can be used for combined photothermo-chemotherapy for yielding synergistic effects. The antitumor activity of the system was evaluated both in vitro and in vivo using the HCT116 colon cancer cell and tumor model. The combination therapy was found with an enhanced treatment efficiency and no obvious side effect. Most importantly, the thermal effect was also discovered with the ability to modulate the tumor microenvironments and suppress the macrophages polarization towards the M2 pro-tumor phenotype. It could be a mechanism for photothermal immunotherapy. The combination strategy and the system provide a potential method for cancer therapy. (C) 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. |
资助项目 | National Basic Research Program of China (973 Program)[2014CB931900] ; National Basic Research Program of China (973 Program)[2013CB932503] ; NSFC, China[81373357] ; NSFC, China[81422048] ; NSFC, China[81673382] ; NSFC, China[81521005] |
WOS关键词 | TUMOR-ASSOCIATED MACROPHAGES ; CARBON NANOTUBES ; THERAPY ; CANCER ; NANOPARTICLES ; DOXORUBICIN ; NANOSHELLS ; COVERAGE ; ABLATION ; SILICA |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
WOS记录号 | WOS:000426437100009 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/272324] |
专题 | 药物制剂研究中心 |
通讯作者 | Huang, Yongzhuo |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 2.Univ Sci & Technol China, Nano Sci Tech Inst, Suzhou 215123, Peoples R China; 3.Shanghai Univ, Coll Sci, Shanghai 200444, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Dongdong,Zhang, Meng,Xu, Fan,et al. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation[J]. ACTA PHARMACEUTICA SINICA B,2018,8(1):74-84. |
APA | Li, Dongdong.,Zhang, Meng.,Xu, Fan.,Chen, Yingzhi.,Chen, Binfan.,...&Huang, Yongzhuo.(2018).Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation.ACTA PHARMACEUTICA SINICA B,8(1),74-84. |
MLA | Li, Dongdong,et al."Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation".ACTA PHARMACEUTICA SINICA B 8.1(2018):74-84. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论